112 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:08am
for Company shares under the Company BIP Trust as well as for other Company shares. (5) Voting rights will not be exercised during the trust term … of residual properties (3) Company shares (5) Direction not to exercise voting rights Policy on Stock Compensation Plan for Directors (1) Resolution
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
in the 3rd quarter.
- 19 -
Translation for reference purpose only
(6) Information on voting rights
1) Total number of shares
As of December 31, 2023 …
Classification
Number of shares
(Shares)
Number of voting rights (Units)
Description
Shares without voting rights
Shares with restricted voting rights
(Treasury
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
their voting rights. e. Cross-Shareholdings - Principle 1.4 The Company only holds shares of other companies with which it has business relationships … environment into consideration. The Company decides whether to exercise its voting rights on cross-shareholdings after conducting a comprehensive review
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
on voting rights
1) Total number of shares
As of September 30, 2023
Classification
Number of shares
(Shares)
Number of voting rights (Units … )
Description
Shares without voting rights
Shares with restricted voting rights
(Treasury stock and other)
Shares with restricted voting rights
(Others)
Shares
6-K
TAK
Takeda Pharmaceutical Co
1 Aug 23
Current report (foreign)
6:10am
-
Translation for reference purpose only
(6) Information on voting rights
1) Total number of shares
As of June 30, 2023
Classification
Number of shares …
(Shares)
Number of voting rights (Units)
Description
Shares without voting rights
Shares with restricted voting rights
(Treasury stock and other)
Shares
6-K
EX-99.1
wm5gzm4fhtwy zq2
12 Jul 23
Current report (foreign)
6:07am
6-K
6d3j54 3dkg
3 Jul 23
Current report (foreign)
6:02am
S-8
EX-99.2
iqga 7uarr
28 Jun 23
Registration of securities for employees
6:35am
6-K
EX-99.1
004qyey
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
up1o5jej
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
0qx6ah8
30 May 23
Current report (foreign)
6:11am
6-K
iw7diboe0kkyl
11 May 23
Current report (foreign)
6:10am
6-K
4xh52rj
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
tbo lqyaxs8j5hlu
4 Nov 22
Current report (foreign)
6:01am
6-K
62moiaj 1w
4 Aug 22
Current report (foreign)
6:07am
6-K
4bx2 74enehxowakz9e
11 Jul 22
Current report (foreign)
6:05am
6-K
b6ife5wi09tnu95z0
5 Jul 22
Current report (foreign)
6:09am
S-8
EX-99.1
t0qx s96h
29 Jun 22
Registration of securities for employees
6:13am